Support First Things by turning your adblocker off or by making a  donation. Thanks!

Big Biotech is mounting a clever—it should be, considering the tens of millions being spent on its propaganda campaign—strategy to keep research cloning legal. Here’s how the gambit would work: Pour millions of campaign and advocacy dollars into conservative states to induce voters to pass laws or constitutional amendments protecting any research allowed by federal law. Promote these laws by, 1)Hyping the potential for CURES! CURES! CURES!, 2) Obfuscating the biology of the issue, such as redefining the term cloning so that an explicit legalization of cloning can pose as a ban, and 3) Sponsoring spurious studies that promise hundreds of billions in economic benefit to the state if the amendment will only be passed. And work the ever-compliant media to set aside any skepticism in pursuit of the cause of science. (Well, that isn’t work, actually, it is a given.)

Then, at the federal level, simply impede any effort to create reasonable regulatory prohibitions against human cloning.

The model is Amendment 2 in Missouri. But I am now hearing from people in Nebraska who have noticed the early rumblings of a similar campaign likely to be mounted there. And polling was just published in Georgia that seems geared clearly toward these same ends.

This makes Missouri the key. If Amendment 2 is defeated, Big Biotech and its propagandists will have to go back to the drawing board. If it passes, watch for the game plan to repeated throughout Red State America.

Dear Reader,

You have a decision to make: double or nothing.

For this week only, a generous supporter has offered to fully match all new and increased donations to First Things up to $60,000.

In other words, your gift of $50 unlocks $100 for First Things, your gift of $100 unlocks $200, and so on, up to a total of $120,000. But if you don’t give, nothing.

So what will it be, dear reader: double, or nothing?

Make your year-end gift go twice as far for First Things by giving now.
GIVE NOW

Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles